Related Experiment Video
Updated: Aug 20, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Cardiovascular risk markers in hemodialysis patients
1Unità Operativa di Nefrologia e Dialisi, Ospedale S. Marta e S. Venera, Acireale CT, Italy.
Insights
Hemodialysis patients often have misdiagnosed heart attacks due to unreliable markers. This study found that cardiac troponin I and CK-MB mass levels remain stable during hemodialysis, suggesting their utility in diagnosing ischemic heart disease in these patients.
Area of Science:
- Nephrology
- Cardiology
- Clinical Chemistry
Background:
- Cardiovascular events are a leading cause of mortality in hemodialysis patients.
- Acute myocardial infarction diagnosis is challenging in uremic patients due to elevated cardiac biomarker false positivity.
- Previous studies indicate predialytic troponin T and CK-MB mass correlate with adverse cardiac events.
Purpose of the Study:
- To evaluate the impact of standard hemodialysis (HD) and on-line hemodiafiltration (HDF) on serum troponin I and CK-MB mass levels.
- To determine if these cardiac biomarkers can be reliably used for diagnosing ischemic heart disease in hemodialysis patients.
Main Methods:
- A prospective study comparing 16 uremic patients on standard HD with 6 patients on on-line HDF.
- Exclusion of patients with pre-existing cardiac ischemic disease.
- Measurement of pre- and post-dialysis serum troponin I and CK-MB mass, along with other parameters like Kt/V and URR%.
Main Results:
- Serum troponin I and CK-MB mass did not significantly change pre- vs. post-dialysis in either HD or on-line HDF groups.
- In standard HD, postdialytic troponin I correlated with serum sodium, potassium, and chlorine.
- Postdialytic CK-MB mass correlated with serum chlorine in standard HD and serum potassium in on-line HDF.
Conclusions:
- Hemodialytic treatments (standard HD and on-line HDF) do not alter serum troponin I and CK-MB mass levels.
- These cardiac biomarkers can be utilized for the diagnostic approach to acute or chronic ischemic heart disease in hemodialysis patients.
- The stability of these markers supports their clinical utility despite potential confounding factors in uremic patients.
Abstract:
Cardiovascular events are the main cause of death in hemodialysis patients. Nevertheless, acute myocardial infarction may be misdiagnosed in uremic patients, because typical markers have a high rate of false positivity. A recent two-year prospective study showed that predialytic high serum concentrations of troponin T and CK-MB mass were associated with high mortality, cardiac mortality, myocardial infarction and unstable angina (MACEs). We studied 16 uremic patients (13 M; 3 W) on standard HD and 6 patients (4 M; 2 W) on on-line HDF, who had been taking folic acid for at least three months. Patients who suffered from acute or chronic cardiac ischemic disease were excluded. Anthropometric parameters, pre and post-dialytic pH, HCO3 and electrolytes did not differ between the two groups. Kt/V and URR% were lower in conventional HD vs on-line HDF (p < 0.04; p < 0.04). ORR% was strongly elevated in on-line HDF compared with HD (p < 0.005). In conventional HD, ORR% was directly correlated with Kt/V and URR% (r = 0.49, p < 0.04; r = 0.48, p < 0.04, respectively). Even in on-line HDF ORR% was directly correlated with Kt/V and URR% (r = 0.79, p < 0.04; r = 0.76, p < 0.05, respectively). Troponin I and CK-MB mass were not significantly different in pre vs post-dialysis, both in standard HD and on-line HDF. Nevertheless, in standard HD postdialytic troponin I correlated with serum sodium concentration (r = 0.93, p < 0.000), potassium (r = 0.67, p < 0.004) and serum chlorine (r = 0.92, p < 0.92, p < 0.000). CK-MB mass showed a correlation with serum chlorine (r = 0.49, p < 0.05). Postdialytic CK-MB mass correlated with serum potassium in on-line HDF (r = 0.83, p < 0.03). Our data suggest that hemodialytic treatments, both standard HD and on-line HDF, do not modify serum troponin I and CK-MB mass. Consequently, we can use these parameters for the diagnostic approach in acute or chronic ischemic heart disease in hemodialysis patients.
Related Concept Videos
Hemodialysis III: Nursing Management
Hemodialysis II: Procedure and Complications
Chronic Kidney Disease II: Clinical Manifestations
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Hemodialysis I: Introduction
Chronic Kidney Disease I: Introduction
